Genycell will distribute the Sophia Data Driven Medicine platform as part of a package to laboratories and hospitals in Spain and Portugal.
The MD Anderson researchers aim to combine computational and functional approaches to investigate genomic alterations as novel therapeutic targets.
The project aims to sequence nine different taxa of cultivated potato and one closely-related wild species to facilitate the production of improved varieties of the crop.
Under the terms of the pact, the partners will integrate Translational's pharmacogenetics knowledgebase and interpretation platform with Xifin's laboratory information system.
The company is developing a search application that will allow users to explore genomic datasets without accessing sensitive information.
In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.
Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."
Ivan Oransky discusses the need for reproducibility research at The Conversation.
The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.